People with schizophrenia will have a new treatment option for the first time in more than three decades, after the Food and Drug Administration Thursday approved a new kind of drug. Studies ...

A new drug has been approved for the treatment of schizophrenia in adults. On Thursday, the U.S. Food and Drug Administration (FDA) approved COBENFY (xanomeline and trospium chloride), an oral ...

The medication, Cobenfy, combines two drugs and is taken as a twice-daily pill. The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with ...

A man has been arrested on suspicion of sending sexual messages to a child in Coventry. He was detained in Walsgrave on Monday (September 23). Officers arrested the 39-year-old man, who has not ...

However, lithium may also be an effective treatment for schizophrenia. Schizophrenia is a complex mental health condition that causes various symptoms, including hallucinations and delusions.

Formally known as KarXT, xanomeline-trospium chloride (Cobenfy) receives approval from the FDA for the treatment of schizophrenia in adults. The FDA approved xanomeline and trospium chloride ...

Experts expressed enthusiasm Friday after US health regulators approved the first new form of treatment for schizophrenia in decades. The drug, called Cobenfy and developed by US pharma giant ...

Wall Street analysts and state financial monitors are raising questions about the fiscal health of Coventry as its school system grapples with growing debt. Days after Moody's canceled Coventry's ...